Published peptide research references
Bortezomib
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.
Source identity and connection checked by Codex (AI).
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.
DOI: 10.1038/s41591-024-03485-7
Source identity and connection checked by Codex (AI).
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Source identity and connection checked by Codex (AI).
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Usmani SZ
- Facon T
- Hungria V
- Bahlis NJ
- Venner CP
- Braunstein M
- Pour L
- Martí JM
- Basu S
- Cohen YC
- Matsumoto M
- Suzuki K
- Hulin C
- Grosicki S
- Legiec W
- Beksac M
- Maiolino A
- Takamatsu H
- Perrot A
- Turgut M
- Ahmadi T
- Liu W
- Wang J
- Chastain K
- Vermeulen J
- Krevvata M
- Lopez-Masi L
- Carey J
- Rowe M
- Carson R
- Zweegman S
- Sonneveld P
- Dimopoulos MA
- Boccadoro M
- Quach H
- Ho PJ
- Antonioli E
- Leleu X
- Mangiacavalli S
- Cavo M
- Belotti A
- Broijl A
- Gay F
- Mina R
- Nijhof IS
- van de Donk NWCJ
- Katodritou E
- Schjesvold F
- Sureda Balari A
- Rosiñol L
- Delforge M
- Roeloffzen W
- Silzle T
- Vangsted A
- Einsele H
- Spencer A
- Hajek R
- Jurczyszyn A
- Lonergan S
- Liu Y
- Vieyra D
- van Brummelen EMJ
- Vanquickelberghe V
- Sitthi-Amorn A
- de Boer CJ
- Rodriguez-Otero P
- Bladé J
- Moreau P
- PERSEUS Trial Investigators
- Leleu XP
- Hájek R
- Liu Z
- Minarik J
- Romejko-Jarosinska J
- Spicka I
- Vorobyev VI
- Besemer B
- Ishida T
- Janowski W
- Kalayoglu-Besisik S
- Parmar G
- Robak P
- Zamagni E
- Goldschmidt H
- Martin TG
- Manier S
- Mohty M
- Oprea C
- Brégeault MF
- Macé S
- Berthou C
- Bregman D
- Klippel Z
- Orlowski RZ
- IMROZ Study Group
- Hus M
- Zherebtsova V
- Ward C
- Ribas de Almeida AC
- Kim K
- Sia H
- Bryant A
- Pitombeira de Lacerda M
- Aparecida Martinez G
- Sureda Balarí AM
- Sandhu I
- Cerchione C
- Ganly P
- Dimopoulos M
- Fu C
- Garg M
- Abdallah AO
- Oriol A
- Gatt ME
- Rifkin R
- Fujisaki T
- Mielnik M
- Pirooz N
- McKeown A
- McNamara S
- Zhou X
- Nichols M
- Lewis E
- Rogers R
- Baig H
- Eccersley L
- Roy-Ghanta S
- Opalinska J
- Mateos MV
- DREAMM-7 Investigators